PET/CT scan for tracking kidney scarring
Part of Kidney & urinary clinical trials.
This trial uses a special PET/CT scan to look at kidney scarring (fibrosis) in people with chronic kidney disease. It could help doctors monitor kidney damage without needing a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic kidney disease.
- You had a kidney biopsy within the last 2 weeks.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special PET/CT scan using a new tracer to measure kidney function and predict how much kidney function will remain after surgery to remove part of a kidney. It may help doctors better plan surgery and manage your care.
This trial tests a new type of PET scan to better see kidney tumors. It may help doctors understand the tumor better before biopsy or surgery.
This early (Phase 1) study compares two types of PET-CT scans to see how well they detect and measure lung scarring (pulmonary fibrosis). It may help doctors choose the best scan test for diagnosis in the future.
This trial tests a new PET/CT scan that uses a special tracer to find clear cell kidney cancer. If you are scheduled for kidney tumor removal, this scan may help your surgeon see the cancer more clearly before surgery.
This trial uses two types of PET scans to better target radiation therapy in patients with advanced clear cell kidney cancer that has spread or returned. The goal is to combine radiation with standard drug treatments to improve outcomes.
This trial tests a special PET scan that may help doctors see if a complex kidney cyst is cancerous before surgery. It is for people who are already scheduled to have surgery to remove a kidney mass.
Hear when a new CKD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.